New Fortress Energy
NFE
DexCom
DXCM
Ermenegildo Zegna NV
ZGN
SilverCrest Metals
SILV
Workday
WDAY
US Stock MarketDetailed Quotes
ONCY Oncolytics Biotech
- 0.820
- -0.067-7.60%
Trading Dec 20 13:53 ET
63.20MMarket Cap-3.28P/E (TTM)
0.900High0.820Low347.24KVolume0.870Open0.887Pre Close297.72KTurnover0.46%Turnover RatioLossP/E (Static)77.07MShares1.53052wk High10.00P/B62.12MFloat Cap0.71052wk Low--Dividend TTM75.76MShs Float7.400Historical High--Div YieldTTM9.02%Amplitude0.351Historical Low0.857Avg Price1Lot Size
Oncolytics Biotech Key Stats
EPS
According to the latest financial report of Oncolytics Biotech, the latest earnings per share (TTM) for the company is -0.12. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: CAD
Quarterly
Loading...
FCF
Interested in knowing about Oncolytics Biotech's free cash flow? The latest report shows it as -4.86M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: CAD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Oncolytics Biotech shows that the company's current ratio is 2.99, indicating healthy liquidity.
Currency: CAD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Oncolytics Biotech, the quick ratio is 2.57, indicating that the company can meet its short-term debt obligations.
Currency: CAD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Oncolytics Biotech? The latest ROE figure is -69.74%, indicating that the company has stable profitability.
Currency: CAD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Oncolytics Biotech, the total asset return on investment (ROA) is -33.88%.
Currency: CAD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Oncolytics Biotech's latest financial report to see how their gross margin is doing - currently at --.
Currency: CAD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Oncolytics Biotech, the net profit margin is --, which is a good sign for its profitability.
Currency: CAD
Quarterly
Loading...
